Saha Rashmita, Singh Vijay Pratap, Samuel Stephen Rajan, Acharya K Vishak, Acharya Preetam Rajgopal, Kumar K Vijaya
Department of Physiotherapy, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Department of Physiotherapy, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education.
Multidiscip Respir Med. 2024 Jun 5;19(1):950. doi: 10.5826/mrm.2024.950.
Pulmonary fibrosis is a chronic, progressive lung condition that involves lung tissue scarring and thickening. The effects of home-based pulmonary rehabilitation (PR) in post-covid pulmonary fibrosis (PCPF) and other forms of fibrosis together have not been evaluated. This study aims to evaluate the effectiveness of home-based pulmonary rehabilitation on pulmonary function, functional capacity, and health-related quality of life in people with pulmonary fibrosis (post-COVID pulmonary fibrosis, pulmonary fibrosis secondary to pulmonary tuberculosis (TB), pulmonary fibrosis secondary to interstitial lung disease (ILD), pulmonary fibrosis secondary to bronchiectasis).
A single-group pretest-posttest experimental study was performed after recruiting 98 pulmonary fibrosis subjects from K.M.C hospitals. After being screened for the inclusion and exclusion criteria, 45 subjects were analyzed, and 6 subjects were lost to follow-up. A home-based pulmonary rehabilitation program was carried out for 8 weeks (warm-up, stretching exercises, aerobic exercise, strength training for upper limb and lower limb, breathing exercises mainly involved; others: energy saving techniques, controlled coughing techniques, dyspnea relieving positions). The program was supervised via weekly phone calls. Pulmonary function (Pulmonary function test), exercise capacity (6-minute walk test), dyspnea (modified Borg scale), and health-related quality of life (SF-36) were evaluated before and after the intervention. During the enrollment and after the 6-minute walk test, saturation of peripheral oxygen (SPO2) level was also evaluated pre-intervention and after the 8-weeks program.
Pulmonary function [FVC(L) t = -12.52, p<0.05; FEV1(L) t = -2.56, p<0.05; FEV1/FVC t = 7.98, p<0.05 and DLCO (ml/min/mmHg) t = -5.13, p<0.05], 6MWD [MD 88.66; p<0.05] and HRQOL measured by SF-36 scores (p<0.05) were improved significantly. Both the baseline SPO2 level before the 6MWT [MD 1.07, p<0.05] and the SPO2 level after the 6MWT [MD 1.16, p<0.05] showed a significant improvement. The rating of perceived exertion(dyspnea) [MD 1.30, p<0.05] was reduced significantly after the 8-week program.
Our study shows that home-based pulmonary rehabilitation is an effective option for improving lung function and physical functional capacity by reducing dyspnea perception and improving the saturation of peripheral oxygen (SPO2) level, and enhancing the quality of life in people with pulmonary fibrosis.
肺纤维化是一种慢性进行性肺部疾病,涉及肺组织瘢痕形成和增厚。居家肺康复(PR)对新冠后肺纤维化(PCPF)及其他形式纤维化的综合影响尚未得到评估。本研究旨在评估居家肺康复对肺纤维化患者(新冠后肺纤维化、肺结核(TB)继发肺纤维化、间质性肺疾病(ILD)继发肺纤维化、支气管扩张继发肺纤维化)肺功能、功能能力及健康相关生活质量的有效性。
从K.M.C医院招募98名肺纤维化受试者后进行单组前后测实验研究。在筛选纳入和排除标准后,对45名受试者进行分析,6名受试者失访。开展为期8周的居家肺康复计划(包括热身、伸展运动、有氧运动、上肢和下肢力量训练、主要的呼吸练习;其他:节能技术、控制咳嗽技术、缓解呼吸困难的体位)。该计划通过每周电话进行监督。在干预前后评估肺功能(肺功能测试)、运动能力(6分钟步行试验)、呼吸困难(改良Borg量表)及健康相关生活质量(SF - 36)。在入组时和6分钟步行试验后,还在干预前和8周计划后评估外周血氧饱和度(SPO2)水平。
肺功能[用力肺活量(FVC,L)t = -12.52,p < 0.05;第一秒用力呼气容积(FEV1,L)t = -2.56,p < 0.05;FEV1/FVC t = 7.98,p < 0.05;一氧化碳弥散量(DLCO,ml/min/mmHg)t = -5.13,p < 0.05]、6分钟步行距离[平均差(MD)88.66;p < 0.05]以及通过SF - 36评分测量的健康相关生活质量(p < 0.05)均有显著改善。6分钟步行试验前的基线SPO2水平[MD 1.07,p < 0.05]和6分钟步行试验后的SPO2水平[MD 1.16,p < 0.05]均有显著改善。8周计划后,主观用力程度(呼吸困难)评分[MD 1.30,p < 0.05]显著降低。
我们的研究表明,居家肺康复是一种有效的选择,可通过减轻呼吸困难感知、提高外周血氧饱和度(SPO2)水平、改善肺功能和身体功能能力,并提高肺纤维化患者的生活质量。